Study title: Furosemide Pharmacokinetics and Pharmacodynamics in health and disease – An Update - Hammarlund-Udenaes M. et al. - 1989 (Journal of pharmacokinetics and biopharmaceutics, Vol 17, No.1) Publication in Clinical Expert Report - Dr Matti VERHO 05/1999 - Volume 18
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Cardiovascular Diseases [C14] | |||||
Brands: Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: FUROSEMIDE | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |